Yaz, Yasmin and Ocella, contained Drospirenone

Yaz, Yasmin and Ocella continue to make news headlines as The New Jersey judiciary considered a mass tort status. Currently, there are 39 lawsuits pending against the drug manufacturers in New Jersey counties and 10 lawsuits in Texas. The consideration was based on the expected increase in plaintiffs, geographic locations of the parties involved, and one judge oversee the efficiency in the case. The lawsuits allege prescription contraceptives drugs Yaz, Yasmin and Ocella contained Drospirenone, not marketed in this country before its use in the Yaz, Yasmin and Ocella drugs. Recently, studies released from the British Medical Journal showed that women taking Drospirenone were at a higher risk of forming venous blood clots, as opposed to women who took other name brand birth control contraceptives. Drospirenone is not present in any other type of oral contraceptive on the market and is allegedly unlike any other progestin (mini-pills, implant and shot form) in the United States.

If you or a loved one has suffered an injury from using prescription contraceptives drugs Yaz, Yasmin and Ocella, call M&A Law Firm toll free at 1-866-789-1664 to discuss your case with a knowledgeable product liability attorney.


Leave a Reply

Your email address will not be published. Required fields are marked *